CYP2C19 GENOTYPING / EDTA BLOOD

image not found

NABL Cap Accredited 

The CYP2C19 Genotyping EDTA Blood test identifies genetic variations that influence how an individual metabolizes certain medications, including antiplatelet and psychiatric drugs. Metropolis Healthcare performs this test using advanced molecular diagnostic techniques to provide accurate and clinically useful pharmacogenetic information. It helps clinicians personalize medication choice and dosage, improving treatment safety and efficacy. When interpreted with clinical history, it supports truly individualized therapy.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 7,845.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes: C0213

Frequently Asked Questions (FAQ's):

What does the CYP2C19 genotyping test include at Metropolis Healthcare?
It includes molecular detection of genetic variants affecting drug metabolism.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses validated molecular assays and strict quality controls.

Why is this test important?
It helps predict drug response and reduce risks of adverse effects.

Who should take this test at Metropolis Healthcare?
Patients prescribed medications metabolized by CYP2C19 or those with unexplained drug responses.

Do I need special preparation before the test?
No special preparation is required; an EDTA blood sample is sufficient.

How can results help clinicians at Metropolis Healthcare?
Results guide personalized drug selection and dosage adjustment.

Are results influenced by diet or lifestyle?
No, results reflect inherited genetic variation and are not affected by daily habits.

When can I receive my report from Metropolis Healthcare?
Reports are provided within the standard turnaround time for genetic testing.

 
 

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab